Correlation Between 23Andme Holding and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Oramed Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Oramed Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Oramed Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Oramed is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Oramed Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Oramed Pharmaceuticals. In addition to that, 23Andme Holding is 1.46 times more volatile than Oramed Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 273.00 in Oramed Pharmaceuticals on August 26, 2024 and sell it today you would lose (39.00) from holding Oramed Pharmaceuticals or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| 23Andme Holding |
| Oramed Pharmaceuticals |
23Andme Holding and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Oramed Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| 23Andme Holding vs. Eliem Therapeutics | 23Andme Holding vs. HCW Biologics | 23Andme Holding vs. Scpharmaceuticals | 23Andme Holding vs. Milestone Pharmaceuticals |
| Oramed Pharmaceuticals vs. Capricor Therapeutics | Oramed Pharmaceuticals vs. Akari Therapeutics PLC | Oramed Pharmaceuticals vs. Soleno Therapeutics | Oramed Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |